A gene called EFEMP2 is linked to worse survival in glioblastoma
Original title: EFEMP2 Is Associated with Shelterin-Related DNA Damage Repair, Immune Microenvironment Features, and Prognosis in Glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was old patient records plus tests on cells in a dish, not a treatment.
The short version
Early lab and record work ties one gene to a poorer outlook in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a brain tumor.
What was studied. Researchers looked at gene data and health records from brain tumor patients. They used four public patient groups, 583 people in all, plus 65 patients from their own hospital. They also turned the EFEMP2 gene off in tumor cells in a lab.
What they found. Patients with high levels of the EFEMP2 gene lived less long. High EFEMP2 also went along with immune cells that do not fight the tumor well. When the team shut the gene off in lab cells, the cells grew, moved, and spread less. The team built a risk score from these genes. It did sort patients into higher and lower risk groups, but it was only fair at telling them apart.
What this means, and what it doesn't
What it could mean: This is a clue about why some glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary tumors resist treatment. It may point future research toward new drug targets. It is not a test or a treatment your doctor can use today.
What it doesn't mean: This does not mean there is a new treatment. No drug aimed at this gene was given to any patient. The patient part was a look back at old gene and health records, not a trial. The rest was done on cells in a dish. This is very early science, far from everyday care, and it is not a promise of a cure.
Source: PubMed, August 7, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.